GLP-1 Agonists: A Potential Game-Changer for Addictive Behavior

A complicated research paper was published just a few weeks ago on the Nature website that introduces some exciting new findings about how GLP-1 agonist medications like semaglutide, Ozempic, Mounjaro, Wegovy, and trizepatide may be capable of doing far more than just treating diabetes and obesity. One of the most impressive findings indicates that addictive […]

The Gila monster gave the weight-loss revolution its bite

It’s currently estimated that over one-half of the adult US population is either overweight or obese. Being overweight means having a Body Mass Index (BMI) between 25 and 30. Obese means a BMI higher than 30. This statistic shouldn’t be taken to indicate neglect by the healthcare, research, or pharmaceutical industry. In reality, enormous attention […]

Treating Obstructive Sleep Apnea with Tirzepatide

Interrupted breathing during sleep, technically known as Obstructive Sleep Apnea (OSA), is a fairly common problem that has, until now, been difficult to address with pharmaceutical treatment. OSA has one quite special characteristic, in that people living with the condition often don’t know that they have it because it occurs only when they are sound […]

What You Need to Know About Wegovy for Weight Loss

Wegovy, the latest form of semaglutide GLP-1 weight-loss medication, has received a flood of media and public attention thanks to the effectiveness of weight management with Wegovy, which promotes rapid and sustainable weight and waistline reductions. Since we added it to our inventory, we have received a lot of positive feedback from our customers, many of which […]

Medicare now approves weight-loss drugs for people with heart problems

There has been much attention in the media to an announcement from Medicare in mid-March 2024. In essence, it said that it has now agreed to start paying for one of the leading weight-loss drugs for people with heart problems when it is prescribed to treat overweight or obese patients if they are at risk […]

Can Metformin be used for more than just diabetes?

Metformin has a long history as a substance with some medical value. It dates back even before its official recognition in 1918 for its ability to reduce blood sugar levels. Before any medical knowledge about diabetes, herbalists utilized a plant called Galega officinalis (also known as goat’s rue or French Lilac) to treat people who […]

World Obesity Week 2024

As we have highlighted previously, World Obesity Week used to be scheduled in November each year. This year, by consensus of the many governmental and international bodies engaged in public health promotion, it has been moved to March, with the start of Obesity Care Week, which runs from the 4th to the 8th of March.  […]

Food Fight: Can Legislation Tackle Obesity?

At the end of October 2023, Governor Gavin Newsom of California signed a trailblazing law set to take effect in 2027. The new law is aimed at forcing food producers to incorporate new levels of safety into their recipes for their products manufactured in the state and sold in California and elsewhere around the country. […]

Weaning off weight-loss meds?

A number of our customers have asked us for advice about their options regarding their desire to stop using the new weight-loss drugs that have taken the world by storm. Primarily, people want to know how to minimize any possible consequences of weaning off Wegovy and its earlier version Ozempic. These new drugs brought improved […]

What’s the difference between Ozempic and Mounjaro?

Ozempic / Wegovy and Mounjaro / Zepbound (and their base components semaglutide and tirzepatide) are currently the “hottest” medications on the market. You don’t have to be a doctor or pharmacist to get to this conclusion; the stock market tells the story. Sales of Ozempic / Wegovy (based on semaglutide) from Novo Nordisk and Mounjaro / […]